MARKET

AKYA

AKYA

Akoya Biosciences, Inc.
NASDAQ
2.850
-0.050
-1.72%
After Hours: 2.850 0 0.00% 17:42 05/17 EDT
OPEN
2.920
PREV CLOSE
2.900
HIGH
2.970
LOW
2.770
VOLUME
403.08K
TURNOVER
0
52 WEEK HIGH
8.80
52 WEEK LOW
2.650
MARKET CAP
140.75M
P/E (TTM)
-1.9382
1D
5D
1M
3M
1Y
5Y
Analysts’ Top Healthcare Picks: Akoya Biosciences (AKYA), Rubicon Organics (ROMJF)
TipRanks · 2d ago
AKOYA BIOSCIENCES INC <AKYA.O>: STEPHENS CUTS TARGET PRICE TO $6 FROM $7
Reuters · 4d ago
JAN, MTC and PROK among mid-day movers
On the Move JAN, MTC and PROK among mid-day movers. Faraday Future Intelligent Electric (FFIE) and AMC Entertainment Holdings (AMC) gain. Augmedix (AUGX) is one of many companies to lose ground.
Seeking Alpha · 5d ago
Akoya Biosciences Price Target Cut to $6.00/Share From $10.00 by Canaccord Genuity
Dow Jones · 5d ago
Akoya Biosciences Is Maintained at Buy by Canaccord Genuity
Dow Jones · 5d ago
Canaccord Genuity Maintains Buy on Akoya Biosciences, Lowers Price Target to $6
Benzinga · 5d ago
Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Alibaba Group Holding Limited fell sharply during Tuesday's session following mixed first-quarter financial results. The e-commerce giant reported revenue growth of 7% year-on-year but missed the analyst consensus estimate of $. Cheetah Net Supply Chain Service Inc. Shares jumped 136% to $ after a follow-on public offering.
Benzinga · 5d ago
Akoya Biosciences Is Maintained at Buy by BTIG
Dow Jones · 5d ago
More
About AKYA
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).

Webull offers Akoya Biosciences Inc stock information, including NASDAQ: AKYA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AKYA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AKYA stock methods without spending real money on the virtual paper trading platform.